NTCELL Clinical Study results to be announced on Friday 10 November
Results of NTCELL® Clinical Study in Parkinson’s
Results released to ASX on Friday 10 November
Company to host conference call on Friday 10 November at 2:00pm AEST / 4:00pm NZT
LCT has announced a trading halt ahead of the announcement of the results of the Phase IIb clinical study of NTCELL in Parkinson's disease on Friday 10 November.
Investor call
LCT CEO Ken Taylor and Principal Investigator Dr Barry Snow will host an investor call to discuss the results of the Phase IIb clinical study of NTCELL in Parkinson's disease on the day of the announcement.
Date: Friday 10 November 2017 Time: NZT 4:00pm, AEST 2:00pm
Conference ID: 3389168
Toll-free dial-in numbers for participants: Australia - 1800 123 296 New Zealand - 0800 452 782 Canada - 1855 5616 766 China - 4001 203 085 Hong - Kong 800 908 865 India - 1800 3010 6141 Japan - 0120 985 190 Singapore - 800 616 2288 United Kingdom - 0808 234 0757 United States - 1855 293 1544 or toll +61 2 8038 5221